bell
The current prices are delayed by 15 mins, login to check live prices.
Laurus Labs Ltd share price logo

Laurus Labs Share Price

(LAURUSLABS)

₹576.9▲1.26%

as on 04:01PM, 21 Jan 2025

Option Chain

Overview
News
Financials
Q3 2024 Results
Technicals
F&O

Laurus Labs Analyst Rating

based on 14 analysts

HOLD

46.67%

Buy

6.67%

Hold

46.67%

Sell

Based on 14 analysts offering long term price targets for Laurus Labs. An average target of ₹445.5

Source: S&P Global Market Intelligence

Laurus Labs Share analysis

Laurus Labs price forecast by 14 analysts

Downside of-23.75%

High

₹710

Target

₹445.50

Low

₹293

Laurus Labs target price ₹445.5, a slight downside of -23.75% compared to current price of ₹576.9. According to 14 analysts rating.

Source: S&P Global Market Intelligence

Laurus Labs Performance

  • Day's Low

    Day's High

    ₹575.2
    Day's Price Range
    ₹593.2

  • 52 Week's Low

    52 Week's High

    ₹360.85
    52-Week Price Range
    ₹619.4
1 Month Return+ 3.21 %
3 Month Return+ 25.58 %
1 Year Return+ 46.45 %
Previous Close₹584.25
Open₹585.10
Volume11.32L
Upper Circuit-
Lower Circuit-
Market Cap₹31,500.38Cr

Laurus Labs Key Statistics

P/E Ratio240.43
PEG Ratio-54.64
Market Cap₹31,500.38 Cr
P/B Ratio5.02
EPS3.12
Dividend Yield0.2
SectorPharmaceuticals
ROE5.41

Laurus Labs Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Laurus Labs Ltd
Laurus Labs Ltd
HOLD₹31,500.38 Cr124.51%0.67₹168 Cr₹5,040 Cr
Dr Lal Pathlabs Ltd
Dr Lal Pathlabs Ltd
HOLD₹23,575.92 Cr14.92%0.55₹362 Cr₹2,226 Cr
Alkem Laboratories Ltd
Alkem Laboratories Ltd
HOLD₹62,628.15 Cr24.45%0.56₹1,811 Cr₹12,667 Cr
Vijaya Diagnostic Centre Ltd
Vijaya Diagnostic Centre Ltd
BUY₹10,982.38 Cr14.51%0.64₹119 Cr₹547 Cr
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd
BUY₹4,447.34 Cr10.57%0.54₹69 Cr₹571 Cr
See all

Laurus Labs Mutual Fund Holdings

About Laurus Labs

Laurus Labs is a fully integrated pharmaceutical and biotechnology company with a leadership position in the production of generic active pharmaceutical ingredients (APIs) in high-growth therapeutic areas like antiretrovirals (ARVs), Hepatitis C, and Oncology. The company operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh, and has invested significantly in their RD and manufacturing infrastructure, having launched 59 products since its inception in 2005. Its key customers include Aspen Pharmacare Limited, Aurobindo Pharma Limited, Cipla Limited, Mylan Laboratories Limited, NATCO Pharma, Strides Shasun, among others. It has 34 owned patents plus 152 pending patent applications in various countries. It is increasingly focused on their integrated generics finished dosage forms FDFs business, having acquired of Sriam Labs and Richcore Lifesciences in the recent years. During 2020, it launched Hydroxychloroquine, initiated TLD supplies for the Global Fund tender, and bargained partnerships with various private and public organizations. On 2022, it infused capital in Laurus Generics Inc . and infused around Rs 46 crore to acquire a stake in Immunoadoptive Cell Therapy Private Limited, among other expansions and operations.

Share Price: ₹576.90 per share as on 21 Jan, 2025 04:01 PM
Market Capitalisation: ₹31,500.38Cr as of today
Revenue: ₹1,223.70Cr as on September 2024 (Q3 24)
Net Profit: ₹17.72Cr as on September 2024 (Q3 24)
Listing date: 19 Dec, 2016
Chairperson Name: M V G Rao
OrganisationLaurus Labs
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Laurus Labs Ltd

  • Laurus Labs Shows Strong Support and Upward Potential - 21 Jan, 2025

    Laurus Labs has found strong support at ₹580, with trends indicating steady buying interest. The stock shows potential for upward traction, suggesting buying opportunities.

  • Laurus Labs Ltd Gains for Third Straight Session - 20 Jan, 2025

    Laurus Labs Ltd surged 3.11% to Rs 585.45, marking its third consecutive day of gains. The stock has risen 46.75% over the past year, outperforming NIFTY and Nifty Pharma index. Volume today was 9.9 lakh shares, below the monthly average of 18.42 lakh shares.

  • Laurus Labs Faces Penalty but Sees No Financial Impact - 15 Jan, 2025

    The Income Tax Department imposed a Rs 3.86 crore penalty on Laurus Labs for disallowed deductions. However, the company stated that the penalty would not impact its finances, as the ITAT had previously allowed the deduction in November 2024.

  • Laurus Labs Reaches Two-Year High Amid Positive Outlook - 07 Jan, 2025

    Laurus Labs shares hit a two-year high, rising 44% in three months, driven by expectations of healthy earnings growth and improved EBITDA margins in FY25. The company anticipates robust growth supported by new contracts and a favorable industry environment.

  • Laurus Labs Poised for Turnaround with Strong Outlook - 04 Jan, 2025

    Laurus Labs is showing signs of a potential turnaround, driven by a strong order book and project deliveries. Bajaj Broking recommends buying shares in the ₹555 - ₹575 range, targeting ₹710, indicating a potential upside of 26% over the next 12 months.

  • Laurus Labs Hits 52-Week High Amid Positive Outlook - 01 Jan, 2025

    Laurus Labs reached a 52-week high of Rs. 606.1, showing a 38.03% annual increase. Analysts recommend buying at lower levels, anticipating further gains.

  • Laurus Labs Hits 52-Week High, Strong Growth Expected - 31 Dec, 2024

    Laurus Labs has reached a 52-week high of Rs. 597.3, with strong performance and growth expectations in oncology and FDF sales. Bajaj Broking lists it as a top pick for 2025 with a target price of Rs 710.

  • Laurus Labs Hits 52-Week High with Strong Gains - 30 Dec, 2024

    Laurus Labs has reached a 52-week high of Rs 593, gaining 5.77% over five days. The stock has outperformed the sector and Nifty indices significantly over the past year.

  • Laurus Labs Secures Investment and Bullish Outlook - 23 Dec, 2024

    Laurus Labs' subsidiary Laurus Bio received a Rs 120 crore investment. Bajaj Broking predicts the stock will break key resistance and target Rs 710.

Insights on Laurus Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 33.69% to 34.10% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 27.18% to 27.60% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, LAURUSLABS stock has moved up by 16.7%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.19K Cr → 1.22K Cr (in ₹), with an average increase of 2.5% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 12.51 Cr → 19.84 Cr (in ₹), with an average increase of 37.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 95.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 13.8%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 8.25% to 7.62% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 26.08% to 25.56% in Dec 2024 quarter

Laurus Labs Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹1,224.45Cr (-)₹1,194.92Cr (↓2.41%)₹1,439.67Cr (↑20.48%)₹1,194.91Cr (↓17.00%)₹1,223.70Cr (↑2.41%)
Net Income₹39.32Cr (-)₹25.17Cr (↓35.99%)₹75.32Cr (↑199.25%)₹12.21Cr (↓83.79%)₹17.72Cr (↑45.13%)
Net Profit Margin3.21% (-)2.11% (↓34.27%)5.23% (↑147.87%)1.02% (↓80.50%)1.45% (↑42.16%)
Value in ₹ crore
Details2021202220232024
Total Assets₹5,740.30Cr (-)₹6,690.16Cr (↑16.55%)₹7,003.02Cr (↑4.68%)₹7,721.10Cr (↑10.25%)
Total Liabilities₹3,028.06Cr (-)₹3,301.95Cr (↑9.05%)₹2,946.20Cr (↓10.77%)₹3,514.05Cr (↑19.27%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹344.68Cr (-)₹694.45Cr (↑101.48%)₹822.97Cr (↑18.51%)₹881.55Cr (↑7.12%)₹658.54Cr (↓25.30%)

Index Inclusions

Nifty Smallcap 250

₹16,484.10

-2.12 (▲-357.3%)

Nifty Smallcap 50

₹8,341.95

-2.09 (▲-178.3%)

S&P BSE 400 MidSmallCap

₹11,370.96

-1.96 (▲-227.24%)

BSE Healthcare

₹42,573.67

-0.96 (▲-412.46%)

S&P BSE 250 SmallCap

₹6,596.39

-2 (▲-134.88%)

Nifty Healthcare

₹14,039.10

-0.7 (▲-99.1%)

NIFTY PHARMA

₹21,882.90

-1.35 (▲-299.5%)

Nifty Small 100

₹17,456.50

-2.28 (▲-408.15%)

BSE Mid-Cap

₹43,167.39

-2 (▲-882.1%)

Nifty 500

₹21,433.20

-1.72 (▲-375.8%)

BSE 500

₹33,693.47

-1.71 (▲-585.6%)

Nifty MidSmallcap 400

₹18,740.20

-2.04 (▲-389.55%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Laurus Labs Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
27.6%
1.58
Foreign Institutions
25.56%
-2.03
Mutual Funds
7.62%
-7.64
Retail Investors
34.1%
1.21
Others
5.12%
6.74

Laurus Labs Key Indicators

Details20202021202220232024
Return On Assets %6.5717.1312.3711.282.08
Details20202021202220232024
Book Value Per Share (₹)33.0248.4162.3774.9676.28
Details20202021202220232024
Earning Per Share (₹)4.7818.3315.4914.793.12
Details20202021202220232024
Return On Equity %15.6842.2324.5920.435.41

Laurus Labs Valuation

Laurus Labs in the last 5 years

  • Overview

  • Trends

Lowest (16.96x)

March 28, 2023

Industry (55.28x)

January 20, 2025

Today (240.43x)

January 20, 2025

Highest (253.35x)

January 1, 2025

LowHigh

Laurus Labs Earnings and Dividends

  • Laurus Labs Ltd Earnings Results

    Laurus Labs Ltd’s net profit fell -46.31% since last year same period to ₹19.84Cr in the Q2 2024-2025. On a quarterly growth basis, Laurus Labs Ltd has generated 58.59% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Laurus Labs Ltd Dividends October,2024

    In the quarter ending September 2024, Laurus Labs Ltd has declared dividend of ₹0.40 - translating a dividend yield of 0.14%.

    Read More about Dividends

Laurus Labs Technicals Summary

Bearish

Neutral

Bullish

Neutral

Laurus Labs Ltd is currently in a Neutral trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Laurus Labs Ltd

Laurus Labs Ltd share price today stands at ₹576.9, Open. ₹585.1 ; Previous Close. ₹584.25 ; High. ₹593.2 ; Low. ₹575.2 ; 52 Week High. ₹619.4 ; 52 Week Low: ₹360.85.

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Laurus Labs Ltd shares.

Laurus Labs Ltd is listed on NSE

Laurus Labs Ltd is listed on BSE

  • Today’s highest price of Laurus Labs Ltd is ₹593.2.
  • Today’s lowest price of Laurus Labs Ltd is ₹575.2.

PE Ratio of Laurus Labs Ltd is 240.43

PE ratio = Laurus Labs Ltd Market price per share / Laurus Labs Ltd Earnings per share

Today’s traded volume of Laurus Labs Ltd(LAURUSLABS) is 11.32L.

Today’s market capitalisation of Laurus Labs Ltd(LAURUSLABS) is ₹31500.38Cr.

Laurus Labs Ltd(LAURUSLABSPrice
52 Week High
₹619.4
52 Week Low
₹360.85

Laurus Labs Ltd(LAURUSLABS) share price is ₹576.9. It is down -6.86% from its 52 Week High price of ₹619.4

Laurus Labs Ltd(LAURUSLABS) share price is ₹576.9. It is up 59.87% from its 52 Week Low price of ₹360.85

Laurus Labs Ltd(LAURUSLABSReturns
1 Day Returns
-7.35%
1 Month Returns
3.21%
3 Month Returns
25.58%
1 Year Returns
46.45%